Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
681.58
-11.65 (-1.68%)
Jan 17, 2025, 4:00 PM EST - Market closed
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
25
Consensus Rating
Buy
Price Target
$1,024.28
Upside
+50.28%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy → Hold Downgrades $1,130 → $738 | Strong Buy → Hold | Downgrades | $1,130 → $738 | +8.28% | Jan 16, 2025 |
| Citigroup | Citigroup | Hold Maintains $895 → $795 | Hold | Maintains | $895 → $795 | +16.64% | Jan 14, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $1,050 → $900 | Buy | Maintains | $1,050 → $900 | +32.05% | Jan 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $1,126 → $1,004 | Strong Buy | Maintains | $1,126 → $1,004 | +47.30% | Jan 8, 2025 |
| Bernstein | Bernstein | Buy Maintains $1,110 → $1,070 | Buy | Maintains | $1,110 → $1,070 | +56.99% | Jan 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Initiates $165 | Hold | Initiates | $165 | -75.79% | Dec 17, 2024 |
| B of A Securities | B of A Securities | Sell Initiates $565 | Sell | Initiates | $565 | -17.10% | Dec 10, 2024 |
| Wolfe Research | Wolfe Research | Buy Initiates $1,150 | Buy | Initiates | $1,150 | +68.73% | Nov 15, 2024 |
| Citigroup | Citigroup | Hold Initiates $895 | Hold | Initiates | $895 | +31.31% | Nov 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $1,150 → $1,000 | Buy | Maintains | $1,150 → $1,000 | +46.72% | Nov 6, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $1,235 → $1,184 | Buy | Maintains | $1,235 → $1,184 | +73.71% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $1,260 → $1,215 | Buy | Maintains | $1,260 → $1,215 | +78.26% | Nov 1, 2024 |
| Barclays | Barclays | Buy Maintains $1,080 → $1,065 | Buy | Maintains | $1,080 → $1,065 | +56.25% | Nov 1, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $1,242 → $1,195 | Buy | Maintains | $1,242 → $1,195 | +75.33% | Nov 1, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $1,300 → $1,190 | Buy | Maintains | $1,300 → $1,190 | +74.59% | Nov 1, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $1,137 → $1,126 | Strong Buy | Maintains | $1,137 → $1,126 | +65.20% | Nov 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.